Tag: Emergency Use Authorization

Consequences of Lack of Funding for Efforts to Combat COVID-19 if Congress Does Not Act

FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant

FDA approves Moderna COVID-19 Vaccine for 18 year olds and older

FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months

Coronavirus (COVID-19) Update: FDA Expands Use of Pfizer-BioNTech COVID-19 Vaccine

FDA approves First Oral Antiviral for Treatment of COVID-19

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment, Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

FDA Coronavirus (COVID-19) Update: November 8th, 2021

FDA approves Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 -11

FDA Takes Additional Actions on Use of Booster Dose for COVID-19 Vaccines